STOCK TITAN

MetLife board reports 16% stake via policyholder trust

The Trust Agreement lets beneficiaries withdraw allocated shares for tender or exchange offers and merger elections or dissenter’s rights.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

MetLife, Inc.’s Board of Directors reported beneficial ownership of 100,527,578 common shares, or 16.0% of the outstanding class, as of October 30, 2026. The shares are held by the MetLife Policyholder Trust; the Board is deemed to beneficially own them because it directs voting on certain matters and reported shared voting power, but no dispositive power.

The Trust’s holdings decreased from 102,098,469 to 100,527,578 shares in transactions reported since July 31, 2026. Under the Trust Agreement, the trustee votes on matters other than Beneficiary Consent Matters according to the Board’s recommendation or direction; those consent matters are voted in proportions reflecting beneficiary instructions. Beneficiaries may receive dividends and sale proceeds on allocated shares.

Filing Explained

The amendment states that Trust beneficiaries may direct the custodian to withdraw allocated shares for resale, to participate in a tender or exchange offer, or, in a merger, to make a cash/share election or exercise dissenters’ rights—transaction-specific choices over shares otherwise held in the Trust.

Beneficial ownership 100,527,578 shares Reported as of October 30, 2026
Percentage of outstanding common stock 16.0% Board of Directors’ reported beneficial ownership
Shared voting power 100,527,578 shares Reported by the Board of Directors
Trust holdings before reported decrease 102,098,469 shares Before the decrease reported in transactions since July 31, 2026
Trust Interests financial
"Trust Interests equal to the number of shares"
shared voting power financial
"has shared voting power with respect to 100,527,578 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dissenter’s rights regulatory
"perfect any dissenter’s rights, in connection with a merger"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MET shares does MetLife’s Board report beneficially owning?

The Board of Directors of MetLife, Inc. reported beneficial ownership of 100,527,578 shares, or 16.0% of the outstanding common stock, as of October 30, 2026. It reported shared voting power over those shares.

Can MetLife Policyholder Trust beneficiaries withdraw MET shares?

Yes. The Trust Agreement permits beneficiaries to instruct the Custodian to withdraw allocated shares for resale or otherwise, to participate in tender or exchange offers, and to make a cash or share election or perfect dissenter’s rights in a merger of MetLife.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





59156R108

(CUSIP Number)
Monica M. Curtis
MetLife, Inc., 200 Park Avenue
New York, NY, 10166-0188
(212) 578-9500

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
11/05/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Unless otherwise indicated, all information relating to beneficial ownership of Shares by the Reporting Persons is as of October 30, 2026.


SCHEDULE 13D


Board of Directors of MetLife, Inc., as an entity
Signature:*
Name/Title:Daniel S. Glaser
Date:11/05/2026
Signature:*
Name/Title:Carla A. Harris
Date:11/05/2026
Signature:*
Name/Title:Laura J. Hay
Date:11/05/2026
Signature:*
Name/Title:R. Glenn Hubbard
Date:11/05/2026
Signature:*
Name/Title:Jeh C. Johnson
Date:11/05/2026
Signature:*
Name/Title:William E. Kennard
Date:11/05/2026
Signature:*
Name/Title:Michel A. Khalaf
Date:11/05/2026
Signature:*
Name/Title:Diana L. McKenzie
Date:11/05/2026
Signature:*
Name/Title:Christian S. Mumenthaler
Date:11/05/2026
Signature:*
Name/Title:Michelle Seitz
Date:11/05/2026
Signature:*
Name/Title:Mark A. Weinberger
Date:11/05/2026
Comments accompanying signature:
*By: /s/ John A. Hall John A. Hall, Attorney-in-fact

Keep reading